Bioithas is a pharmaceutical company specialized in probiotics with clinical indications and biomarkers (pronostic and early diagnosis). The company is led by Vicente Navarro, CEO and Scientific Director with over 26 years experience in medicine and over 16 in infectious diseases who runs the company with passion and conviction. Our drive is to obtain unique biotechnological results, providing a differentiating value to each project. Our misión is to improve people's health and quality of life. We study the Human Microbiota and its connection to diseases. We own patented probiotic blends with indications in Atopic Dermatitis, Psoriais and Acne. We also own the industrial property of a probiotic blend with indications in Covid-19 (digestive symptoms) and two biomarkers for Multiple Sclerosis (prediction) and Head and Neck Cancer (early diagnosis). Please, feel free to contact us if you are interested in any of our patents (patent licensing) or in CRO service.